• HOME
• CONTACT

Publications

• Bidus MA, Maxwell GL, Kulasingam S, Rose GS, Elkas JC, Rodriguez M, Myers ER: Cost effectiveness of cervix cancer screening in an organization that provides both salary and healthcare benefits. (in press, Obstet Gynecol).
• Bidus MA, Webb JC, Seidman JD, Rose GS, Boice CR, Elkas J. Sustained response to bevacizumab in refractory well-differentiated ovarian neoplasms (in press, Gynecol Oncol).
• Farley J, Birrer M. Summary of the Ovarian Cancer State of the Science Meeting, (in press, Gynecol Oncol).
• Farley J, Truong V, Goo E, Uyehara C, Belnap C, Larsen W. A randomized double blind placebo controlled trial of the cyclooxygenase-2 inhibitor celecoxib in the treatment of cervical dysplasia. (in press, Gynecol Oncol).
• Hamilton CA, Berek JS: Intraperitoneal chemotherapy for ovarian cancer. Curr Opin Oncol 2006; in press.
• Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre T, Teng NN, Husain A, Dirbas F, Chan JK: Outcomes of women with metachronous breast and ovarian carcinomas. Gynecol Oncol 2006; in press.
• Maxwell GL, Berchuck A, Rodriguez G, Schildkraut J: The effects of progestin on endometrial cancer risk: A review of the CDC Cancer and Steroid Hormone Study. (in press, Gynecol Oncol).
• Maxwell GL, Risinger JI: Racial disparities research: It's not black and white. (in Press, Gynecologic Oncology).
• Morrison C, Zanagnolo V, Cohn DE, Kelbick N, Copeland L, Maxwell GL, Fowler JM: HER-2 is an independent prognostic factor in human endometrial cancer: association with outcome in a large cohort of surgically staged cases. (in Press: Journal of Clinical Oncology).
• Risinger JI, Chandramouli GVR, Maxwell GL, Custer M, Pack S, Loukinov D, Aprelikova O, Litzi T, Schrump DS, Murphy SK, Berchuck A, Lobanenkov V, Barrett JC: Global expression analysis of cancer testis genes in uterine cancers reveals a high incidence of BORIS expression. (in press, Clinical Cancer Research).
• Risinger JI, Chandramouli GVR, Maxwell GL, Litzi T, Berchuck A, Umar A: Gene expression analysis of tumor infiltrating lymphocyte markers in endometrial cancers indicates no significant increases in those cases with microsatellite instability. (in press, Disease Markers).
• Bidus MA, Risinger JI, Chandramouli G, Dainty L, Litzi T, Berchuck A, Barrett JC, Maxwell GL: Prediction of lymph node metastasis in patients with endometrioid endometrial carcinoma using expression microarray. Clin Cancer Res 2006;12:83-8.
• Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Lum LG, Schulz S, Thorne S, Contag CH, Negrin RS: Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine Induced Killer Cells with Bispecific Antibodies: A Preclinical Study. Clin Cancer Res 2006;12(6):1859-67.
• Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SD, Roman LD. Influence of quantity of lymph-vascular space invasion on recurrence in women with early stage squamous cancer of the cervix. Gynecol Oncol 2006; 100:288-293.
• Farley J, Alexander A, Zahn C, Harrison T, Nielsen P, Branch W, Larsen W, Homas D. Far Forward Gynecologic care of the Female Soldier. J Reprod Med 2006; 51:31-35.
• Hamilton CA, Cheung MK, Osann K, Balzer B, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK: The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol 2006.
• Hamilton CA, Cheung MK, Osann K, Husain A, Teng NN, Kapp DS, Chen LM, Longacre TS, Chan JK: Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancer. Br J Cancer 2006;94(5):642-6.
• Kyser K, Bidus MA, Rodriguez M, Rose GS, Elkas J. Spontaneous pregnancy following cytoreduction with peritonectomy and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol 2006;100:198-200.
• Stany MP, Bidus MA, Reed EJ, Kaplan KJ, Rodriguez M, McHale MT, Rose GS, Elkas J. The prevalence of HPV DNA in ASC-US Pap Smears: A military population study. Gynecol Oncol 2006; 101:82-85.
• Allard JE, Rodriguez M, Parker MF. Biopsy site selection at time of colposcopy and distribution of cervical intraepithelial neoplasia. J Low Genit Tract Dis 2005; 9(1):36-39
• Bidus MA, Elkas JC, Rodriguez M, Maxwell GL, Rose GS: The clinical utility of the diagnostic endocervical curettage. Clin Obstet Gynecol 2005;48:202-8.
• Bidus MA, Maxwell GL, Rodriguez M, Elkas JC, Rose GS: The role of self-collection devices for cytology and human papillomavirsu (HPV) DNA testing in cervical cancer screening. Clin Obstet Gynecol 2005; 48:127-32.
• Bidus MA, Zahn CM, Maxwell GL, Rodriguez M, Elkas J, Rose GS. The clinical utility of the diagnostic endocervical curettage. Clin Obstet Gynecol 2005;48(1):127-132.
• Bidus MA, Zahn CM, Maxwell GL, Rodriguez M, Elkas J, Rose GS. The role of self-collection devices for cytology and human papillomavirus (HPV) DNA testing in cervical cancer screening. Clin Obstet Gynecol 2005;48(1):127-132.
• Dainty LA, Bosco JJ, McBroom JW, Winter WW, Rose GS, Elkas J. Novel techniques to improve split-thickness skin graft viability during vulvo-vaginal reconstruction. Gynecol Oncol 2005;97:949-952.
• Dainty LA, Elkas J, Rose GS, Zahn CM. Controversial topics in abnormal cervical cytology: “see and treat”. Clin Obstet Gynecol 2005;48(1):193-201.
• Elkas J, Berek J, Leuchter R, Lagasse L, Karlan BY. Lower urinary tract reconstruction with ileum in the treatment of gynecologic malignancies Gynecol Oncol 2005;97:685-692.
• Farley J, Heathcock R, Branch W, Larsen W, Homas D. Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment, Obstet Gynecol 2005 May; 105(5):1250-4.
• Farley J, McBroom J, Zahn C. Current techniques for the evaluation of abnormal cervical cytology. Clin Obstet Gynecol 2005 Mar;48(1):133-46.
• Hamilton CA, Liou WS, Osann K, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK: Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys 2005;63(3):839-44.
• Hodgson W, Kaplan K, Rodriguez M, McHale MT, Rose GS, Elkas J. The impact of converting to liquid-based cervical cytology in a military population. Gynecol Oncol 2005;99:422-426.
• Krivak TC, Elkas J, Rose GS, Sundborg M, Winter WE, Carlson J, MacKoul PJ. The utility of hand-assisted laparoscopy in ovarian cancer. Gynecol Oncol 2005;96(1):72-76.
• Maxwell GL, Chandramouli G, Dainty L, Litzi T, Berchuck A, Barrett JC, Risinger J: Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer. Clinical Cancer Research 2005;11:4056-66.
• Miller C, Bernet V, Elkas J, Dainty L, Gherman RB. Conservative management of extra-adrenal pheochromocytoma during pregnancy. Obstet Gynecol 2005;105:1185-1188.
• Miller C, Elkas J. Conservative management of extra-adrenal pheochromocytoma during pregnancy [letter]. Obstet Gynecol. 2005;106:868
• Risinger JI, Maxwell GL, Chandramouli G, Dainty L, Litzi T, Assad U, Berchuck A, Barrett JC: Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling. Cancer Research 2005;65:5031-7.
• Stany M, Winter WE, Elkas J, Rose GS. The use of an acellular dermal graft for vulvar and vaginal reconstruction in a patient with erosive lichen planus. Obstet Gynecol 2005;105:1268-1271.
• Yauger BJ, Rodriguez M, Parker MF. Default from colposcopy and loop excision electrocautery procedure appointments in a military clinic. J Low Genit Tract Dis. 2005; 9(2):78-81.
• You W, Dainty L, Rose G, Krivak T, McHale M, Olsen C, Elkas J. Gynecologic malignancies in women aged less than 25 years. Obstet Gynecol 2005;105:1405-1409.
• Allard J, McBroom J, Maxwell GL: Vaginal metastasis and thrombocytopenia from renal cell carcinoma. Gynecol Oncol 2004;92:970-3.
• Bidus MA, O'Boyle JD, Elkas J. Sentinel lymph node detection in gynecologic malignancies. Postgraduate Obstetrics & Gynecology 2004; 24(26): 1-5.
• Booth C, Zahn CM, McBroom J, Maxwell GL: Retroperitoneal mullerian carcinoma associated with endometrioisis: a case report. Gynecol Oncol 2004;93:546-9.
• Dainty L, Maxwell GL, Clarke-Pearson DL, Myers ER: Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. Gynecol Oncol 2004;93:366-73.
• Farley J, Uyehara C, Hashiro G, Belnap C, Birrer M, Salminen E. Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecol Oncol 2004; 92:596-602.
• Kaplan KJ, Dainty LA, Dolinsky B, Rose GS, Carlson J, McHale M, Elkas J. Prognosis and recurrence risk for patients with cervical squamous intraepithelial lesions when diagnosed during pregnancy. Cancer 2004;4(102): 228-232. Cited and reviewed in ACOG Clinical Review; 2005, Vol. 10(3), 9.
• Maxwell GL: Vaginal metastasis from renal cell carcinoma. Response to a Letter to the Editor Gynecol Oncol.
• Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan, BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman LD, Yu MC, Zempolich K, Dubeau L. Detection of residual, subclinical, ovarian carcinoma after completion of adjuvant chemotherapy. Clin Can Res 2004; 10(8):2681-6
• Winter W, Maxwell GL, Tian C, Rose GS, Thomas G, Carlson J : The association of hemoglobin with survival in advanced cervical carcinoma patients treated with cisplatin and radiotherapy: a study by the Gynecologic Oncology Group. Gynecol Oncol 2004;94:495-501.
• Elkas J, Holschneider CH, Katz B, Li AJ, Louie R, McGonigle KF, Berek JS. The use of continuous infusion topotecan in persistent and recurrent ovarian cancer. Int J Gynecol Cancer 2003;13(2):138-41.
• Farley J, Hickey K, Carlson J, Rose G, Kost E, Harrison T. Adenosquamous histology predicts poor outcome for advanced but not early stage cervical carcinomas. Cancer 2003; 97:2196-2202.
• Farley J, Smith L, Darcy K, O'Conner D, Henderson B, Morrison L, Sobel E, Birrer M. Cyclin E expression is a significant predictor of survival in advanced, suboptimally-debulked ovarian epithelial cancers: A gynecologic oncology group study. Clin Cancer Res 2003; 63:1235-1241.
• Kost E, Hall K, Hines J, Farley J, Nycum L, Rose G, Carlson J, Fischer J, Kendall B. Asian-Pacific Islander race independently predicts poor outcome in patients with endometrial cancer. Gynecol Oncol 2003; 218-226
• Maxwell GL, Dodge R, Synan I, McClelland C, Clarke-Pearson DL: Risk factors which predispose patients to thromboembolism despite prophylaxis with external pneumatic compression. Obstet Gynecol 2003;101:157-63.
• Risinger J, Maxwell GL, Chandramouli G, Jazaeri A, Aprelikova O, Patterson T, Barrett C, Berchuck A: Microarray analysis reveals distinct expression profiles among different histologic types of endometrial cancer. Cancer Research 2003;63:6-11.
• Risinger J, Maxwell GL, Davis B, Zahn C, Berchuck A, Barrett JC: Promotor hypermethylation as an epigenetic component in Type I and Type II endometrial cancers. Ann N Y Acad Sci 2003;983:208-12.
• Winter W, McBroom J, Carlson JW, Rose GS, Elkas J. The utility of gastrojejunostomy in secondary cytoreduction and palliation of proximal intestinal obstruction in recurrent ovarian cancer. Gynecol Oncol 2003;91(1): 261-264.
• Dietrich CS, Yancey MK, Miyazawa K, Williams DL, Farley JH. Risk factors for early cytological abnormalities following loop electrosurgical excision procedure, Obstet Gynecol 2002; 99:188-92.
• Elkas J, Baldwin RL, Pegram M, Tseng Y, Slamon D, Karlan BY. A human ovarian carcinoma murine xenograft model useful for preclinical trials. Gynecol Oncol 2002;87(2):200-206.
• Maxwell G, Ochoa M, Carlson J, Krivak T, Myers E: Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. Obstet Gynecol 2002;100:740.
• Maxwell GL, Synan I, Hayes R, Clarke-Pearson D: Patient preference among gynecologic oncology patients undergoing thromboembolism prophylaxis. Obstet Gynecol 2002;100:451-5.
• Robison SW, Dietrich CS, Person DA, Farley JH. Ethnic Differences in Survival Among Pacific Island Patients Diagnosed with Cervical Cancer. Gynecol Oncol 2002; 84:303-308.
• Winter III WE, Krivak TC, Maxwell GL, Elkas JC, Rose GS, Carlson JW. Modified technique for urinary diversion with incontinent conduits. Gynecol Oncol 2002;86:351-3.
• Winter W, Kucera OR, Rogers W, McBroom JW, Olsen C, Maxwell GL: Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002;100:671-6.
• Alvarez AA, Lambers AR, Tong B, Gumbs C, Marks J, Maxwell GL, Iglehart DJ, Gumbs C, Berchuck A, Futreal PA: Frequent allele loss on chromosome 1p36 is a common feature of ovarian cancers. Gynecologic Oncology 2001;82:94-8.
• Alvarez A, Maxwell GL, Soper J: Use of the Wound Vac in management of enterocutaneous fistulas. Gynecologic Oncology 2001 Mar;80(3):413-6
• Farley J, Heaton J, O'Boyle J. Adenocarcinoma of unknown primary site presenting as an isolated pelvic mass and Trousseau's synDr.ome, Military Med 2001; 166:831-2.
• Farley J, Hines J, Taylor R, Carlson J, Parker M, Kost E, Rogers S, Harrison T, Macri C, Parham G. Equal access ensures equal care for African-American Women with cervical cancer. Cancer 2001; 91;869-73.
• Fowler V, Maxwell GL, Livengood CH: Seronegative syphillis in an AIDS patient with condyloma lata. Arch Dermatol 2001 Oct;137(10):1374-6.
• Maxwell GL, Dodge R, Berchuck A: Microsatellite instability is associated with favorable survival in endometrial carcinomas. Obstet Gynecol 2001;97:417-22.
• Maxwell GL, Synan I, Carney M, Carol B, Hayes R, Clarke-Pearson DL: A prospective randomized trial comparing external pneumatic calf compression stockings to low molecular weight heparin in the prevention of venous thromboembolic events among gynecological oncology patients. Obstet Gynecol 2001;98:989-95.
• Nycum L, Smith L, Farley J, Kost E, Method M, Birrer M. The role of p27 in endometrial carcinoma. Gynecol Oncol 2001; 81:242-246.
• Robinson WR, Hamilton CA, Michaels SH, Kissinger P: Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol 2001;184:538-43.
• Rodriguez M, Dubeau L. Ovarian tumor development: insights from ovarian embryogenesis, Eur J Gynaecol Oncol 2001; 22(3):175-183
• Elkas J, Petit N, Pohl J, Armstrong A, Gray K. Modulation of endometrial steroid receptors and growth regulatory genes by tamoxifen. Obstet Gynecol 2000;95:697-703.
• Farley J, Gray K, Nycum L, Birrer M, Jakowlew S. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1) . Gynecol Oncol 2000;78:113-122.
• Farley J, Heaton J, Remmenga S. Extraosseous ewing's sarcoma of the vagina, Obstet Gynecol 2000; 96:832-4.
• Farley J, Nycum L, Birrer M, Park R, Taylor R. Age specific survival of women with endometrioid adenocarcinoma of the uterus. Gynecol Oncol 2000; 79:86-89.
• Kost E, Kendall B, Hines J, Farley J, Nycum L, Rose S, Carlson J, Hall K, Fischer J. Race and endometrial cancer in the military 2000; US AMEDD J, 10;3-9.
• Maxwell GL, Myers E, Clarke-Pearson DL: Cost-effectiveness of deep venous thrombosis prophylaxis using pneumatic compression, low-dose heparin or low molecular weight heparin in gynecologic surgery. Obstet Gynecol 2000;95:206-14.
• Maxwell GL, Risinger J, Hayes K, Berchuck A, Barrett C, Futreal: Racial disparity in PTEN mutations among patients with advanced endometrial carcinoma. Clinical Cancer Research 2000;6:2009-3005.
• Nagersheth N, Maxwell GL, Bentley R, Rodriguez G: Bilateral lymph node metastasis in a case of microinvasive adenocarcinoma of the cervix. Gynecologic Oncology 2000;77:467-70.
• Schmitz, M, Hendricks, D, Farley, J, Taylor, R, Geradts, J, Rose, G, Birrer, M, p27 and Cyclin D1 abnormalities in uterine papillary serous carcinoma. Gynecol Oncol, 2000;77:439-445.